Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...

Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV vaccine in Africa, where the burden of the virus is still being keenly felt.

A recent study has shown that one dose of Bavarian Nordic’s Jynneos vaccine was overall 58% effective at preventing mpox ...

A groundbreaking project to study potential HIV vaccines in several ... to the development of SARS-CoV-2 vaccines made by the pharmaceutical companies Moderna and Pfizer/BioNTech.

Why not all African countries should venture into vaccine business ANALYSIS | The African Union has embarked on one of its ...

The LC16m8 vaccine is safe and effective in people with well-controlled HIV. Furthermore ... BioNTech’s BNT-166a, and Moderna’s mRNA-1769. Of these, the Phase III trial for LC16m8 includes ...

Vaccines are a powerful tool of modern medicine, protecting you from diseases that once caused widespread suffering and death ...

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...

Vaccine makers were hit particularly hard yesterday, as Marks’ resignation letter alluded to disagreements with HHS Secretary ...

MORE: Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS The opposition ... from melanoma to HIV to Zika, according to clinical trials. The proposed bans ...

Whereas the Pfizer and Moderna COVID-19 vaccines suspend mRNA ... in the general coronaviruses,” she says. Related: Another HIV vaccine fails, highlighting longstanding challenges in the field ...

Moderna's pipeline includes 20 preventative vaccine candidates for infectious diseases including Zika, flu, respiratory syncytial virus (RSV) and HIV, amongst others, as well as cancer.